CN Patent

CN118319871B — 一种司美格鲁肽药物组合物

Assigned to Lunan New Time Bio Tech Co ltd · Expires 2025-08-05 · 1y expired

What this patent protects

本发明属于医药制剂技术领域，具体涉及一种司美格鲁肽药物组合物及其制备方法。本发明司美格鲁肽药物组合物包括司美格鲁肽、富马酸伏诺拉生、N‑(8‑(2‑羟基苯甲酰)氨基)辛酸钠(SNAC)和药学上可接受的辅料，组合物中SNAC用量少，富马酸伏诺拉生能够快速调节pH，并能够长时间停留在胃壁细胞上并更长时间稳定在碱性环境中，提高司美格鲁肽溶出，且制剂稳定性好。

USPTO Abstract

本发明属于医药制剂技术领域，具体涉及一种司美格鲁肽药物组合物及其制备方法。本发明司美格鲁肽药物组合物包括司美格鲁肽、富马酸伏诺拉生、N‑(8‑(2‑羟基苯甲酰)氨基)辛酸钠(SNAC)和药学上可接受的辅料，组合物中SNAC用量少，富马酸伏诺拉生能够快速调节pH，并能够长时间停留在胃壁细胞上并更长时间稳定在碱性环境中，提高司美格鲁肽溶出，且制剂稳定性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN118319871B
Jurisdiction
CN
Classification
—
Expires
2025-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Lunan New Time Bio Tech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.